Toray Industries, Inc. and Astellas Pharma Inc. Announce of the Acquisition of Marketing Approval for the Pulmonary Arterial Hypertension Agent Careload(R) LA Tablets 60mu/g in Japan

Published: Oct 22, 2007

Tokyo, Oct 22, 2007 (JCN Newswire) - Toray Industries Inc. (TSE: 3402) and Astellas Pharma Inc. (TSE: 4503) today announced that Toray has obtained marketing approval for its oral PGI2 derivative prolonged release, Careload(R) LA Tablets 60mu/g (generic name: beraprost sodium), to be indicated for pulmonary arterial hypertension (PAH) on October 19,2007. Careload will be listed in the NHI drug price list and launched in December 2007.

Back to news